These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39224115)

  • 1. Malnutrition and unsuccessful tuberculosis treatment among people with multi-drug resistant tuberculosis in Uganda: A retrospective analysis.
    Engoru S; Bajunirwe F; Izudi J
    J Clin Tuberc Other Mycobact Dis; 2024 Dec; 37():100477. PubMed ID: 39224115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social and health factors associated with adverse treatment outcomes among people with multidrug-resistant tuberculosis in Sierra Leone: a national, retrospective cohort study.
    Kamara RF; Saunders MJ; Sahr F; Losa-Garcia JE; Foray L; Davies G; Wingfield T
    Lancet Glob Health; 2022 Apr; 10(4):e543-e554. PubMed ID: 35303463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malnutrition is a risk factor for tuberculosis disease among household contacts: A case-control study in Uganda.
    Izudi J; Engoru S; Bajunirwe F
    IJID Reg; 2024 Sep; 12():100409. PubMed ID: 39224535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda.
    Izudi J; Tamwesigire IK; Bajunirwe F
    J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100153. PubMed ID: 32123755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.
    Khan FU; Rehman AU; Khan FU; Hayat K; Khan A; Ahmad N; Chang J; Malik UR; Fang Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis.
    Naz F; Ahmad N; Wahid A; Ahmad I; Khan A; Abubakar M; Khan SA; Khan A; Latif A; Ghafoor A
    BMC Infect Dis; 2021 Dec; 21(1):1209. PubMed ID: 34863099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study.
    Panford V; Kumah E; Kokuro C; Adoma PO; Baidoo MA; Fusheini A; Ankomah SE; Agyei SK; Agyei-Baffour P
    BMJ Open; 2022 Jul; 12(7):e062857. PubMed ID: 35790328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
    Bastos ML; Cosme LB; Fregona G; do Prado TN; Bertolde AI; Zandonade E; Sanchez MN; Dalcolmo MP; Kritski A; Trajman A; Maciel ELN
    BMC Infect Dis; 2017 Nov; 17(1):718. PubMed ID: 29137626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda.
    Ategyeka PM; Muhoozi M; Naturinda R; Kageni P; Namugenyi C; Kasolo A; Kisaka S; Kiwanuka N
    BMC Infect Dis; 2023 Mar; 23(1):149. PubMed ID: 36899299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of risk factors associated with multi-drug resistant tuberculosis (MDR-TB) in Gulu regional referral hospital.
    Omona K; Opiyo AM
    Afr Health Sci; 2023 Sep; 23(3):343-357. PubMed ID: 38357137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of bedaquiline containing all oral longer regimens in treating multidrug/rifampicin resistant tuberculosis in Pakistan.
    Khan A; Khan AH; Ahmad N; Ghafoor A
    J Infect Public Health; 2024 Sep; 17(9):102522. PubMed ID: 39173557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
    Okethwangu D; Birungi D; Biribawa C; Kwesiga B; Turyahabwe S; Ario AR; Zhu BP
    BMC Infect Dis; 2019 May; 19(1):387. PubMed ID: 31064332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala, Uganda.
    Batte C; Namusobya MS; Kirabo R; Mukisa J; Adakun S; Katamba A
    Afr Health Sci; 2021 Mar; 21(1):238-247. PubMed ID: 34394303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with unfavorable treatment outcomes among multidrug-resistant tuberculosis patients, Sierra Leone: a cross-sectional secondary data analysis.
    Koroma JA; Elduma AH; Sesay U; Gebru GN
    BMC Infect Dis; 2024 Jun; 24(1):579. PubMed ID: 38862873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for mortality among multi-drug resistant tuberculosis patients in treatment follow-up centers, eastern Ethiopia: a retrospective follow-up study.
    Bofe KU
    Pan Afr Med J; 2022; 43():78. PubMed ID: 36591001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes of multidrug-resistant tuberculosis in Hangzhou, China, 2011 to 2015.
    Li Q; Shi CX; Lu M; Wu L; Wu Y; Wang M; Wang L; Zhao G; Xie L; Qian HZ
    Medicine (Baltimore); 2020 Jul; 99(30):e21296. PubMed ID: 32791713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.